A photo of Yael Haberman Ziv.

Yael Haberman Ziv, MD, PhD

  • Adjunct Assistant Professor, UC Department of Pediatrics


PhD: Tel-Aviv University, Tel-Aviv, Israel, 2006.

MD: Tel-Aviv University, Tel-Aviv, Israel, 2007.

Residency: Pediatrics, Sheba Medical Center, Tel -Hashomer, Israel, 2011.

Fellowship: Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014.

Services and Specialties

Gastroenterology GI, Autoimmune Liver Disease

Research Areas

Gastroenterology Hepatology and Nutrition


Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn's disease, and celiac disease. Braun, T; Sosnovski, KE; Amir, A; BenShoshan, M; VanDussen, KL; Karns, R; Levhar, N; Abbas-Egbariya, H; Hadar, R; Efroni, G; et al. JCI insight. 2023; 8:e170181.

Achieving pan-microbiome biological insights via the dbBact knowledge base. Amir, A; Ozel, E; Haberman, Y; Shental, N. Nucleic Acids Research. 2023; 51:6593-6608.

Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Khandelwal, P; Lounder, DT; Bartlett, A; Haberman, Y; Jegga, AG; Ghandikota, S; Koo, J; Luebbering, N; Leino, D; Abdullah, S; et al. Haematologica: the hematology journal. 2023; 108:1803-1816.

GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis. Sosnovski, KE; Braun, T; Amir, A; Moshel, D; Benshoshan, M; Vandussen, KL; Levhar, N; Abbas-Egbariya, H; Beider, K; Ben-Yishay, R; et al. Journal of Crohn's and Colitis. 2023; 17:960-971.

Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis. Whaley, KG; Xiong, Y; Karns, R; Hyams, JS; Kugathasan, S; Boyle, BM; Walters, TD; Kelsen, J; LeLeiko, N; Shapiro, J; et al. Clinical Gastroenterology and Hepatology. 2023; 21:1338-1347.

Infantile-onset inflammatory bowel disease has variable long-term outcomes. Krauthammer, A; Weintraub, I; Shaoul, R; Lev-Tzion, R; Broide, E; Wilschanski, M; Lerner, A; Yerushalmi, B; Shouval, DS; Shamaly, H; et al. Frontiers in Pediatrics. 2023; 11:1097779.

Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Abbas-Egbariya, H; Haberman, Y; Braun, T; Hadar, R; Denson, L; Gal-Mor, O; Amir, A. Genome Biology: biology for the post-genomic era. 2022; 23:61.

Gut microbiome development in early childhood is affected by day care attendance. Amir, A; Erez-Granat, O; Braun, T; Sosnovski, K; Hadar, R; BenShoshan, M; Heiman, S; Abbas-Egbariya, H; Glick Saar, E; Efroni, G; et al. npj Biofilms and Microbiomes. 2022; 8:2.

Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis. Clarkston, K; Karns, R; Jegga, AG; Sharma, M; Fox, S; Ojo, BA; Minar, P; Walters, TD; Griffiths, AM; Mack, DR; et al. Journal of Crohn's and Colitis. 2022; 16:1735-1750.

Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells - A novel mechanism for maintenance of intestinal inflammation. Lin, SN; Musso, A; Wang, J; Mukherjee, PK; West, GA; Mao, R; Lyu, R; Li, J; Zhao, S; Elias, M; et al. Matrix Biology. 2022; 113:1-21.